|
|
||||||||
1 Dept of Chest Medicine, Hôpital du Sacré-Coeur, Montreal and 2 Joint Depts of Epidemiology and Biostatistics and Occupational Health, McGill University, Montreal, Canada
CORRESPONDENCE: D. Gautrin, Dept of Chest Medicine, Sacré-Coeur Hospital, 5400 Gouin Blvd West, Montreal, Canada, H4J 1C5. Fax: 1514 3383123
Keywords: bronchial responsiveness, immunological sensitization, occupational asthma
Received: March 26, 2001
Accepted September 5, 2001
This study was supported by the Medical Research Council of Canada (grant no MT-12256). D. Gautrin is a research scholar with the Fonds de la Recherche en Santé du Québec (FRSQ).
| Abstract |
|---|
|
|
|---|
A cohort of 417 apprentices in animal-health technology was prospectively followed during 32 or 44 months. The effect on the study outcomes of variables derived from questionnaire, skin reactivity, and lung function assessments at baseline were compared in atopic (n=212) and nonatopic (n=183) subjects.
Eighty-five incident cases of sensitization to a LA-derived allergen were identified, 67 among atopic and 18 among nonatopic subjects. Baseline rhinitis symptoms in contact with pets and skin sensitization to pets were associated with the development of work-related rhinoconjunctivitis (RC) symptoms in atopic subjects, whereas perannual rhinitis symptoms and having a PC20 (provocative concentration causing a 20% fall in forced expiratory volume in one second)
32 mg·mL1 were associated in nonatopic subjects. Baseline rhinitis symptoms on contact with pets and a PC20 value
32 mg·mL1 were significant determinants for developing sensitization to a specific allergen in atopic subjects only. Finally, baseline rhinitis symptoms in contact with pets and perannual rhinitis symptoms were associated with the development of occupational RC in atopic subjects, whereas in nonatopic subjects this was associated with having a PC20 value
32 mg·mL1.
In conclusion, the determinants for the development of specific skin sensitization, symptoms and disease are different between atopic and nonatopic apprentices starting occupational exposure to laboratory-animal-derived allergens.
Exposure to laboratory animal-derived allergens carries a significant risk for immunoglobulin (Ig)-E-mediated sensitization and development of oculonasal and respiratory symptoms as well as occupational rhinoconjunctivitis (RC) and asthma (OA) 1. In a prospective assessment of 342 laboratory-animal workers, Cullinan et al. 2 found that 46 (13%) developed skin reactivity to rat urine over a 3.5-yr period. In a prospective study of 417 apprentices starting exposure to laboratory animals and seen for a 32- to 44-month period, 85 (20%) incident cases of sensitization to at least one laboratory-animal-derived allergen were identified 3. Interestingly, one third of these cases had probable OA as they also developed significant changes in bronchial hyperresponsiveness 4.
As for most high molecular weight occupational allergens, almost all cross-sectional studies on animal workers to date 1 have shown atopy to be a risk factor for sensitization to animal-derived allergens. In a prospective assessment, the present authors found that atopy was a risk factor for skin sensitization although the relative risk (RR) was relatively low (RR=2.2, 95% confidence interval (CI)=1.23.9). The only other factor associated with the development of skin sensitization to animal-derived allergens was the presence of respiratory symptoms in the pollen season (RR=5.2, 95% CI=1.716.1) 3. Although atopic subjects are at greater risk for sensitization, it is known that only one third of subjects will progress to symptomatic state, at least in the first 5 yrs of follow-up after sensitization 5. The positive predictive value of atopy is therefore relatively low and considering that
50% of young adults are currently atopic subjects 6, therefore excluding them from entering a career in which they will be exposed to laboratory animals cannot be recommended. A non-negligible proportion of nonatopic subjects exposed to laboratory animals might also develop skin sensitization. In a pooled survey of 649 workers from four countries who were exposed to laboratory animals, 18/401 (4.5%) nonatopic subjects had skin reactivity to rat urine 7. Among the 85 incident cases of sensitization to a laboratory-animal-derived allergen identified in the present authors' previous study, 18 (21%) had entirely negative skin tests to common allergens 3.
Risk factors for outcomes of allergy might well differ according to atopic status. The present study, therefore, aimed to examine the determinants for the development of skin sensitization to a common allergen (mites) and laboratory animal-derived allergens, as well as the development of work-related oculonasal and respiratory symptoms, occupational RC and probable OA, by examining atopic and nonatopic subjects separately.
| Material and methods |
|---|
|
|
|---|
3 months before entering the program, as assessed in a preliminary visit. Among the 417 subjects initially recruited, 395 attended at least one follow-up visit and had interpretable skin tests results. The study protocol was approved by the Ethical Committee of Sacré-Coeur Hospital, Montreal, Canada. The subjects gave written consent to their participation when recruited in this cohort study.
Study design
The subjects in animal-health technology were reassessed at 8, 20, 32 and 44 months after starting the programme. The majority of students attended the 20- (n=345) and 32-month (n=355) visits. There were 136 students at the 8-month assessment because the others had not been exposed to laboratory animals since starting in the programme; these students were seen at the 20- and 32-month assessments. Finally, 98 subjects attended the longest programme and were seen up to the 44-month assessment.
Study methods
At the time of entry into the apprenticeship programme and at each follow-up visit, each student answered a respiratory questionnaire derived from the standardized questionnaire of the International Union Against Tuberculosis and Lung Diseases (IUATLD) 8. Information was obtained on physician-diagnosed asthma, personal allergic conditions and familial asthma. Symptoms suggestive of asthma included wheezing, chest tightness, shortness of breath, or cough under usual conditions or under such conditions as exercise or exposure to cold air, strong odours, smoke, or dusts. Respiratory symptoms and RC on contact with pets and pollens were also documented.
Skin tests were done with the prick method 9 using 11 common inhalants: mixed trees, mixed grass, and ragweed pollens; Alternaria, Aspergillus, and Hormodendrum; feathers; Dermatophagoides farinae and D. pteronyssinus; and cat and dog dander (Omega, Montreal, Canada). For mite-derived allergens and cat dander, standardized extracts were used. Histamine phosphate (1/200 g·mL1) was used as a positive control, and diluent (glycerine, 50%), as a negative control. The largest weal diameter was assessed 1015 min after introduction of the antigen. A positive reaction was defined as a weal
3 mm in the absence of reaction to the diluent and in the presence of a positive reaction to histamine phosphate. Contrary to a previous publication by the present authors in which atopy was defined as at least two positive reactions to the common inhalants 3, in the present study atopy was defined as one positive reaction in order to have no occurrence in nonatopic subjects at baseline in the case of skin reactions to mites.
In addition, skin-prick tests were performed with extracts of aeroallergens potentially present in the students' working areas, specifically urinary proteins from rat, mouse, and rabbit (Pharmacia Allergon AB, Angelholm, Sweden), as well as rabbit dander (Omega). All extracts were obtained before the beginning of the study in sufficient amounts to perform the total estimated number of skin tests to the end of the project. The skin-prick tests were performed by the same nurse throughout the study.
Skin sensitization to a specific agent was considered positive if sensitization developed at one or the other of the follow-up visits and remained positive at a later visit when three assessments were performed. The same criteria were applied for incident symptoms.
Spirometry with the assessment of forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) was carried out using a Collins apparatus (Survey/1 Plus Collins, Braintree, MA, USA) according to published standards 10. Methacholine inhalation tests were performed using a Wright's nebulizer (Roxon Meditech Ltd, Montreal, Quebec, Canada) (output=0.14 mL·min1) at tidal volume breathing for 2 min according to guidelines slightly modified from those of the European Respiratory Society 11. The procedure for performing the methacholine test was modified as described elsewhere to take into account the absence of an on-site physician 12. The provocative concentration causing a 20% fall in FEV1 (PC20) was interpolated from individual dose-response curves drawn on a semi-logarithmic scale using non-cumulative doses. Reference values for FEV1 and FEV1/FVC were taken from Knudson et al. 13. Bronchial hyperresponsiveness was set at
16 mg·mL1 14.
Exposure assessment
The number of hours spent in contact with rodents was considered as a potential determinant for the development of the outcomes. Three categories (
16, 17
52, >52 h) that best delineated the frequency distribution were set previously 3.
Statistical analysis
The cohort of students was divided into two groups according to atopic status at baseline. The outcomes studied were: 1) skin sensitization to mites; 2) skin sensitization to specific laboratory animal-derived allergens; 3) nasoocular symptoms; 4) work-related respiratory symptoms; 5) occupational RC defined as the association of the development of skin sensitization to at least one specific programme-derived allergen and at least one nasoocular symptom; and 6) probable OA defined as the association of the development of skin sensitization to at least one specific programme-derived allergen and significant changes (3.2-fold difference or more) in PC20. The independent variables in the analyses assessed at baseline included: atopy and immediate skin reaction to pets, history of hay fever, asthma, exercise-induced respiratory symptoms, cold air-induced respiratory symptoms, perannual rhinitis, rhinitis on contact with pets, respiratory symptoms in the pollen season, and familial history of asthma as well as PC20 (dichotomized into
32 versus >32 mg·mL1 and
16 versus >16 mg·mL1). Univariate analyses were used separately for each group to evaluate odds ratios (OR) and 95% CI for the effect of several host factors on each outcome. Multivariate logistic regression analyses were performed for each group and each outcome with the independent variables meeting the 0.10 level of significance in the univariate analyses. In the individual logistic regression analyses to estimate the OR for the incidence of a given outcome, only the subjects free of this condition at baseline were included. Statistical analyses were performed using the SPSS software package. The level of statistical significance was set at p<0.05 (two-sided).
| Results |
|---|
|
|
|---|
|
|
|
8 and
32 mg·mL1 were associated with work-related RC for both atopic and nonatopic subjects. Whereas several factors were significant predictors of work-related respiratory symptoms, occupational rhinoconjunctivits and probable OA in atopic subjects, having a PC20
32 mg·mL1 was the only significant predictor of occupational RC in both atopic and nonatopic individuals.
|
32 mg·mL1) were different. In the case of work-related respiratory symptoms, significant determinants (rhinitis on contact with pets, immediate skin reactivity to pets, a PC20
32 mg·mL1) were found only in atopic subjects. Table 6
32 mg·mL1 were associated with specific immunological sensitization in atopic subjects. No factor was a significant determinant in nonatopic subjects. Perannual rhinitis and immediate skin reactivity to pets were significantly associated with occupational RC in atopic subjects, whereas a PC20
32 mg·mL1 was significantly associated with occupational RC for both atopic and nonatopic subjects. Finally, skin reactivity to pets was significantly associated with probable OA in atopic subjects.
|
|
| Discussion |
|---|
|
|
|---|
32 mg·mL1) and FEV1 4. In this cohort of laboratory workers, 18 of the 85 incident cases of sensitization and six of the 30 incident cases of probable OA were nonatopic. Although atopy is clearly a major risk factor, work-related specific sensitization and probable OA do occur in nonatopic subjects as well. It is therefore of interest to know whether the secondary risk factors differ in atopic and nonatopic subjects. In a previous paper 3, by the present authors, the interaction between atopy and the other factors was not studied in the analysis because of the small number of cases. Therefore, in the study presented here parallel analyses were performed in atopic and nonatopic subjects. Such separate analyses have rarely been carried out. Heederik et al. 7 examined the effect of ranked levels of exposure in 650 atopic and nonatopic subjects exposed to laboratory animals. These authors found that atopic workers in three levels of antigen exposure had a constant three-fold increased sensitization risk compared with nonexposed workers, while nonatopic workers showed an increased sensitization risk with higher exposure category. These findings were confirmed in the present authors study for the development of specific sensitization and occupational rhinoconjunctivitis In the present study, for most analyses, except for work-related respiratory symptoms in nonatopic subjects (n=3), the number of incident outcomes was sufficient to allow firm conclusions. Indeed, when the incidence is <10, the results from a logistic regression analysis may be spurious or imprecise as discussed elsewhere 15.
In atopic subjects, certain factors such as rhinitis on contact with pets and immediate skin reactivity to pets as well as having a PC20
32 mg·mL1 were associated with more than one outcome. The ORs for work-related respiratory symptoms and their CIs, are larger for most risk factors in comparison with the ORs for the other outcomes (i.e., work-related rhinoconjunctivitis, occupational rhinitis or probable OA) (table 4
). This may be a spurious effect, indeed most subjects with work-related respiratory symptoms also have positive skin reaction to pets (20/24) and all, except one, have symptoms of rhinitis in contact with pets (table 5
). However, when rhinitis in contact with pets is taken into account in the multiple logisitic regression analysis, the OR for work-related respiratory symptoms due to skin reaction to pets (OR=6.1) is comparable to the other ORs shown in table 4
.
Rhinitis symptoms on contact with pets and immediate skin reactivity to pets might have been suspected to be reasonable predictors of the likelihood of developing one or the other of the selected outcomes in atopic subjects. In particular, the relationship between the latter risk factor and the development of specific immunological sensitization to laboratory animals could be attributable to cross-immunological reactivity between these mammalian species, as discussed previously 5, 16, major allergens belonging to the "same super-family of proteins" 17. However, increased bronchial responsiveness could not have been so readily suspected. As previously discussed, it would therefore seem interesting to consider following-up subjects exposed to laboratory animals by using both skin-prick testing and bronchial responsiveness assessment 3 although positive predictive values are low, at least for a follow-up of 34 yrs as in the current study (in the order of 3050%).
The most interesting finding of the present study is the fact that not only do a substantial number of nonatopic subjects develop specific sensitization (18/85, 21.2%) and probable OA (6/30, 20%), but the associated factors differ in atopic and in nonatopic subjects. For instance, perannual rhinitis and having a PC20
32 mg·mL1 were significantly associated with the development of work-related RC symptoms in nonatopic subjects, but not in atopic individuals. It is reasonable to assume that having perannual rhinitis symptoms may place someone more at risk to develop work-related RC, and also, that having a PC20
32 mg·mL1 is a reflection of upper and/or lower airways responsiveness. In atopic subjects, these factors are individually associated with the incidence of work-related RC symptoms, but are overshadowed by the presence of atopy, and symptomatology on contact with pets in a multivariate analysis.
The present authors found that smoking was associated with the development of skin reactivity to mites in nonatopic individuals. Although smoking has been associated in some studies with the development of airway hyperresponsiveness, its association with the development of IgE-mediated sensitization to common allergens has not been documented. Increase in total IgE levels is associated with both smoking and atopy, but separately 18, 19. Atopic markers such as increased specific IgE levels and immediate skin reactivity to common inhalants seem to be even less common in smokers 20. Smoking has however been found to be a determinant of IgE-mediated sensitization to such occupational agents as psyllium 21 and platinum salts 22. However, smoking was not found to be associated with the development of specific skin reaction to laboratory animals in previously published studies by Cullinan et al. 2 and Heederik et al. 7. The results of the present study, obtained in nonatopic subjects and with a small number of cases, are in accordance with these findings. However, the results of this study do not provide a clear statement on the role of cigarette smoking in the development of the outcomes studied here. The absence of an association between smoking sensitization and work-related allergens could be due to the young age of the subjects (mean age 19.5±2.9 yrs). Including such subjects allowed the present study, however, to observe the effects of work-related exposure independently of the effects of smoking.
The incidence of skin sensitization to mites was higher in atopic than in nonatopic subjects which was expected. However, the incidence of sensitization to this common allergen was lower than for most work-related outcomes.
The prospective design of this study performed in a cohort of apprentices, enabled the present authors to assess the subjects' baseline atopic and airway responsiveness status, and medical history before any/or not more than 3-months exposure to the occupational allergens took place. This approach allows reduction in the bias that may otherwise be present when a cohort is assembled after some years of exposure 23. In addition, it allows the natural history of the development of specific sensitization and OA to be studied, which is difficult in the case of common asthma as discussed elsewhere and as presented when the study was initiated 6.
In conclusion, as determinants of sensitization, symptoms and diseases differ in atopic and nonatopic subjects, it might be suggested to use such discrete analyses in population surveys.
| Acknowledgements |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |